How To Make Your Drug Development Project More Attractive to Investors
Believe it or not, 2024 might actually be a record year for pharmaceutical investment, but most of that money is not being directed toward drug discovery. My perspective is this: Many pharmaceutical and biotech venture capitalists are once-bitten,...
Insider Strategies for High-Yield Investments in Pharma
We are long past the era when drug development was a convenient byproduct of pure chance. Now, steady innovation tends to require steady capital. But, after 2021, venture capitalists have been understandably hesitant to invest in an industry where...
Pitfalls To Avoid in the Drug Development Process
90% of clinical trials fail. That statistic has been passed around so often that it no longer raises eyebrows in our industry, but we believe it should. Frankly, we find this statistic both unacceptable and unnecessary. To be clear, the path to...
Common Regulatory Delays and How To Prevent Them
Drug development can be an incredibly rewarding journey, which is what has attracted most of us to this industry. Whenever we attend industry events, we find ourselves surrounded by relentless optimists. However, the process can be extraordinarily...
What Are Some CDMOs Not Telling You?
There are 300 CDMOs to choose from, but we’ve found that those who compete solely on price often lack the skills many projects will need to be successful. Our team created a comprehensive guide with everything you need to know before you sign with any CDMO — including us!
